COVID-19 vaccinations summary

Second Boosters Administered 982,800
Total Doses Administered 12,666,524
First Boosters Administered 2,773,363
Percentage of 12+ who have completed primary course 90.1%
Percentage of eligible 50+ who have received second booster 55.1%
Percentage of eligible 18+ who have received first booster 73.0%

 

Metrics on this page can use one of two views of the data. An operational view or a person view. There are two main differences between the views which result in slightly different totals.

  • Occasionally doses that are recorded as first doses in CIR are actually a person's second doses. This means they will appear as dose 1 in the operational view but will appear as completed primary course in the person view (this is a data entry issue only and does not impact the dose that the person received).
  • Those who have been vaccinated overseas will only appear in the person view, they will not appear in the operational view.

In short, the operational view shows how doses administered in New Zealand were recorded in CIR. The person view shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand.

Total Vaccinations

  Vaccinations last week Cumulative total
First dose 20 4,032,039
Second dose 13 3,985,246
Third primary 3 34,662
Booster 1 175 2,773,363
Booster 2 912 982,800
Booster 3 1,590 427,557
Paediatric First Dose 25 271,694
Paediatric Second Dose 30 158,276
Infant First Dose 1 139
Infant Second Dose 2 114
Infant Third Dose 1 64
Total doses 2,840 12,666,524

This table is an operational view.

Definitions

  • Cumulative total: All vaccinations that have been administered and entered into the COVID-19 Immunisation Register and including Friday 29 September 2023.
  • Vaccinations last week:  Over the 7 days up to and including Friday 29 September 2023.

Booster breakdowns

Booster counts by ethnicity

Ethnicity Booster 1 (16-17) Booster 1 (18+) Booster 2 (50+)
Māori 1,053 254,639 61,668
Pacific Peoples 706 154,952 27,162
Asian 2,129 461,008 59,685
European/Other 6,312 1,824,706 668,735
Unknown 33 19,266 3,637
Total 10,233 2,714,571 820,887

This table is a person view.

Booster 2 uptake by age group

Age Group Eligible Received Uptake
12 to 17 - 148 -
18 to 34 - 34,622 -
35 to 49 634,981 109,689 -
50 to 64 729,923 280,806 38.5%
65+ 759,115 540,081 71.1%

This table is a person view.

Vaccine uptake percentage by age band

A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand.

Vaccine uptake percentage by District of residence 12+

A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered.

Note, this figure does not include 5-11 year olds

* Note, this figure does not include 5-11 year olds

Vaccinations by week

A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week.

This chart shows the count of vaccinations administered in a given week from the COVID-19 Immunisation Register. Note some records are entered in the register at a later date than the immunisation was received. This means that the figures for a given date may move for some time after that date.

Adverse events following immunisations (AEFI)

Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, don’t last long and won’t stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.

Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). Medsafe is closely monitoring the AEFI reported from the use of the COVID-19 vaccine and will report regularly on their findings.
 

View Medsafe data on COVID-19 vaccine adverse effects following immunisation